Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: Implications of interferon and phosphodiesterase 4D-interacting protein

Keiko Nishizawa, Ayumi Oguma, Maki Kawata, Yuji Sakasegawa, Kenta Teruya, Katsumi Doh-ura

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A new type of antiprion compound, Gly-9, was found to inhibit abnormal prion protein formation in prion-infected neuroblastoma cells, in a prion strain-independent manner, when the cells were treated for more than 1 day. It reduced the intracellular prion protein level and significantly modifiedmRNAexpression levels of genes of two types: interferon-stimulated genes were downregulated after more than 2 days of treatment, and the phosphodiesterase 4D-interacting protein gene, a gene involved in microtubule growth, was upregulated after more than 1 day of treatment. A supplement of interferon given to the cells partly restored the abnormal prion protein level but did not alter the normal prion protein level. This interferon action was independent of the Janus activated kinase-signal transducer and activator of transcription signaling pathway. Therefore, the changes in interferon-stimulated genes might be a secondary effect of Gly-9 treatment. However, gene knockdown of phosphodiesterase 4D-interacting protein restored or increased both the abnormal prion protein level and the normal prion protein level, without transcriptional alteration of the prion protein gene. It also altered the localization of abnormal prion protein accumulation in the cells, indicating that phosphodiesterase 4D-interacting protein might affect prion protein levels by altering the trafficking of prion protein-containing structures. Interferon and phosphodiesterase 4D-interacting protein had no direct mutual link, demonstrating that they regulate abnormal prion protein levels independently. Although the in vivo efficacy of Gly-9 was limited, the findings for Gly-9 provide insights into the regulation of abnormal prion protein in cells and suggest new targets for antiprion compounds.

Original languageEnglish
Pages (from-to)4083-4099
Number of pages17
JournalJournal of virology
Volume88
Issue number8
DOIs
Publication statusPublished - 2014 Apr

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Fingerprint Dive into the research topics of 'Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: Implications of interferon and phosphodiesterase 4D-interacting protein'. Together they form a unique fingerprint.

  • Cite this